Send this to a friend

Dual CEO Almassian tees up CaroGen's next stage

With decades of biotech industry experience under his belt, Bijan Almassian may be approaching one of his most significant career milestones yet: Raising millions of dollars for a startup he co-founded, which is developing a vaccine platform to treat multiple deadly viruses and other conditions, including Hepatitis B.

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media